Substance Use & Co-Occurring Disorders

Co-occurring disorders (also called dual diagnosis or comorbidity) means having both a substance use disorder and a mental health disorder at the same time. This is extremely common—about 50% of people with severe mental illness also have a substance use disorder, and about 37% of people with alcohol use disorder and 53% with other drug use disorders also have at least one serious mental illness (SAMHSA, 2024). Common combinations include: depression + alcohol use disorder, PTSD + substance use disorder, bipolar disorder + stimulant or alcohol use, anxiety disorders + benzodiazepine or alcohol dependence, schizophrenia + cannabis use disorder. The relationship is bidirectional: mental illness increases risk of substance use (self-medication, impulsivity, shared risk factors), and substance use worsens mental health (neurotoxicity, disrupted treatment, social consequences). ICD-10 codes specify both conditions (e.g., F33.2 major depression recurrent severe + F10.20 alcohol use disorder moderate).

The self-medication hypothesis, proposed by Dr. Edward Khantzian, suggests that people use substances to cope with painful psychiatric symptoms or emotional states they don't know how to manage otherwise. Examples: using alcohol to reduce social anxiety before social situations, using stimulants to counteract depression's fatigue and low motivation, using opioids to numb emotional pain from trauma, using cannabis to manage PTSD nightmares and hyperarousal. While substances may provide short-term relief, they worsen mental health long-term through multiple mechanisms: neurotransmitter depletion (alcohol and stimulants deplete dopamine and serotonin), sleep disruption (nearly all substances impair sleep architecture), interfering with psychiatric medications, causing or worsening depression/anxiety during withdrawal, creating new problems (legal, financial, relationship) that worsen mental health. The self-medication pattern creates a vicious cycle: psychiatric symptoms → substance use for relief → temporary improvement → worsening symptoms (rebound anxiety, depression) → increased substance use. Effective treatment requires addressing the underlying psychiatric condition with proper medication and therapy so self-medication becomes unnecessary.

Historically, addiction treatment and mental health treatment were separate systems with different philosophies. Addiction programs often refused to treat people with mental illness ('get stable first'), while mental health programs refused to treat active substance users ('get clean first'). This left dual diagnosis patients bouncing between systems, getting incomplete treatment for both conditions. SAMHSA's integrated treatment model recognizes that co-occurring disorders interact—each affects the course and treatment of the other. Integrated treatment means: (1) Both conditions treated simultaneously by the same provider or coordinated team; (2) Recognition that both are primary—neither is just a symptom of the other; (3) Psychiatric medications managed throughout recovery (not discontinued because 'all drugs are bad'); (4) Mental health symptoms addressed in addiction counseling; (5) Substance use addressed in psychiatric treatment; (6) Motivational enhancement rather than confrontational approaches; (7) Expectation of slower progress—dual diagnosis recovery takes longer. Research consistently shows integrated treatment produces better outcomes than sequential or parallel treatment: higher engagement, better retention, fewer hospitalizations, improved functioning, reduced substance use and psychiatric symptoms.

Absolutely yes. This is one of the most harmful myths in addiction treatment—that taking psychiatric medication is 'not really being sober' or means you're 'replacing one drug with another.' This is dangerously wrong. Psychiatric medications treat medical conditions (depression, anxiety, bipolar disorder, schizophrenia). Untreated mental illness is a major relapse risk factor. The distinction: addiction involves compulsive use despite harm, tolerance, withdrawal, and using substances to get high. Psychiatric medications: prescribed for medical conditions, taken as directed, don't produce euphoria, prevent symptoms rather than getting high. Taking an SSRI for depression is equivalent to taking insulin for diabetes or blood pressure medication for hypertension—it's medical treatment, not addiction. Modern recovery-oriented treatment recognizes that optimal addiction recovery often requires psychiatric medication for co-occurring mental illness. In fact, treating depression, anxiety, PTSD, or bipolar disorder with appropriate medication significantly improves substance use outcomes. Some recovery communities (certain 12-step groups) may stigmatize psychiatric medication, but this is changing. Work with an addiction psychiatrist who understands both conditions and can help you determine which medications are safe and helpful versus which carry addiction risk.

Most psychiatric medications are safe and appropriate for people in recovery from substance use disorders. Safe medications include: SSRIs/SNRIs (sertraline, escitalopram, duloxetine, venlafaxine) for depression and anxiety—no abuse potential, don't interact with recovery; Mood stabilizers (lithium, valproate, lamotrigine) for bipolar disorder—essential for preventing manic episodes that often trigger relapse; Antipsychotics (risperidone, quetiapine, aripiprazole) for bipolar disorder, schizophrenia, severe depression—no addiction potential; Non-addictive sleep medications (trazodone, hydroxyzine, melatonin); Gabapentin for anxiety or neuropathy—slight abuse potential in some, but generally safe; Naltrexone (oral or Vivitrol injection) for alcohol/opioid use disorder—blocks euphoric effects. Medications requiring caution: Benzodiazepines (alprazolam, clonazepam, lorazepam)—high addiction potential, cross-tolerance with alcohol. Generally avoided in alcohol/sedative use disorder history. If absolutely necessary for severe anxiety/panic, use longer-acting ones (clonazepam), close monitoring, time-limited. Stimulants (Adderall, Ritalin) for ADHD—can be safely used in stimulant use disorder history with close monitoring, but non-stimulant options (atomoxetine, guanfacine) often preferred initially. Sleep medications (Ambien, Lunesta)—some abuse potential, use cautiously. An addiction psychiatrist can determine which medications are appropriate for your specific situation.

If you have both substance use issues and mental health symptoms, you need both—integrated dual diagnosis treatment. However, the intensity and setting depends on severity. Need addiction treatment (residential/IOP/outpatient) if: Unable to stop using despite wanting to; withdrawal symptoms when trying to quit; substance use causing major life problems (legal, job loss, relationship breakdown); failed outpatient attempts; using daily or near-daily; medically dangerous withdrawal (alcohol, benzodiazepines) requiring detox; co-occurring severe mental illness with active substance use. Need psychiatric treatment (medication management + therapy) if: Persistent depression, anxiety, mood swings independent of substance use; symptoms that pre-dated substance use; symptoms that persist during periods of sobriety; family history of mental illness; suicidal thoughts; psychotic symptoms; inability to function due to psychiatric symptoms. Often both are needed: addiction treatment (group therapy, recovery skills, peer support, drug testing, intensive structure) PLUS psychiatric treatment (medication for depression/anxiety/bipolar, individual therapy for trauma/mental health). The key is coordination between providers. At RECO Integrated Psychiatry, we coordinate with addiction treatment programs, providing psychiatric medication management and therapy while you engage in addiction treatment, ensuring both conditions are addressed.